Molecules 2017, 22, 1482
11 of 15
(E)-N0-((3-(4-Bromophenyl)-1-(p-tolyl)-1H-pyrazol-4-yl)methylene)-2-((4-methyl-2-oxo-2H-chromen-7-yl)
◦
oxy)acetohydrazide (31). Yield 83%; m.p. = 248–251 C; Rf = 0.47; 1H-NMR (ppm): 2.35 (s, 3H, CH3), 2.49
(s, 3H, CH3), 4.76–5.11 (s, 2H, CH2), 6.22 (s, H, CH), 6.88–7.87 (12H, arom), 8.97 (s, H, CH), 11.47 (s, H,
NH); 13C-NMR (ppm): 18.1, 20.4, 65.2, 101,7, 111.4,118.4, 121.8, 126.4, 129.9, 130.4, 131.4, 131.7, 136.5,
153.3, 154.5, 160.1; MS m/z: 570.80 [M − H]+, (Mr = 571.43).
(E)-N0-((3-(4-iodophenyl)-1-(p-tolyl)-1H-pyrazol-4-yl)methylene)-2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)
1
acetohydrazide (32). Yield 73%; m.p. = 265 ◦C; Rf = 0.45; H-NMR (ppm): 2.26 (s, 3H, CH3), 2.41 (s,
3H, CH3), 5.32 (s, 2H, CH2), 6.21 (s, H, CH), 6.95–7.79 (12H, arom), 8.97 (s, H, CH), 10.91 (s, H, NH);
13C-NMR (ppm): 18.1, 65.2, 95.8, 101.6, 111.2,112.3, 113.3, 126.3, 128.3, 129.5, 130.4, 137.5,147.8, 153.2,
154.6, 160.0, 161.4; MS m/z: 617.20 [M − H]+, (Mr = 618.08)
(E)-N0-((3-(4-methoxyphenyl)-1-(p-tolyl)-1H-pyrazol-4-yl)methylene)-2-((4-methyl-2-oxo-2H-chromen-7-yl)
oxy)acetohydrazide (33). Yield 93%; m.p. = 238 ◦C; Rf = 0.41; 1H-NMR (ppm): 2.36 (s, 3H, CH3), 2.40 (s,
3H, CH3), 3.79-3.83 (s, 3H, OCH3), 4.78–5.18 (s, 2H, CH2), 6.22 (s, H, CH), 7.05-8.12 (12H, arom), 8.94 (s,
H, CH), 11.48 (s, H, NH); 13C-NMR (ppm): 18.6, 20.9, 55.7, 101.9, 111.7,112.7, 114.4, 118.9, 126.9, 128.4,
130.2, 130.4, 136.7, 137.3, 147.8, 153.8, 168.3; MS m/z: 521.40 [M − H]+, (Mr = 522.2).
(E)-N0-((3-(4-Chlorophenyl)-1-(p-tolyl)-1H-pyrazol-4-yl)methylene)-2-((4-methyl-2-oxo-2H-chromen-7-yl)
oxy)acetohydrazide (34). Yield 65%; m.p. = 255 ◦C; Rf = 0.47; 1H-NMR (ppm): 2.36 (s, 3H, CH3), 2.40 (s,
3H, CH3), 4.79–5.13 (s, 2H, CH2), 6.23 (s, H, CH), 6.90–8.12 (12H, arom), 8.98 (s, H, CH), 11.50 (s, H,
NH); 13C-NMR (ppm): 18.6, 20.9, 101.9, 102.2, 111.7, 112.7, 119.1, 119.3, 126.9, 129.0, 129.2, 130.5, 130.6,
153.8; MS m/z: 525.30 [M − H]+, (Mr = 526.98).
(E)-N0-((1-(4-Chlorophenyl)-3-(4-nitrophenyl)-1H-pyra◦zol-4-yl)methylene)-2-((4-methyl-2-oxo-2H-chromen-7-
1
yl)oxy)acetohydrazide (35). Yield 69%; m.p. = 281 C; Rf = 0.42; H-NMR (ppm): 2.40 (s, 3H, CH3),
4.81–5.09 (s, 2H, CH2), 6.23 (s, H, CH), 6.86–8.47 (12H, arom), 9.11 (s, H, CH), 11.59 (s, H, NH);
13C-NMR (ppm): 18.6, 101.9, 111.8, 112.6, 121.5, 124.1, 124.2, 126.8, 130.0, 130.2, 168.4; MS m/z: 556.30
[M − H]+, (Mr = 557.94).
0
(E)-N -((4-Chloro-2-oxo-2H-chromen-3-yl)methylene)-2-((4-methyl-2-oxo-2H-chromen-7-yl)oxy)acetohydrazide
(
36). Yield 78%; m.p. = 233 ◦C; Rf = 0.28; 1H-NMR (ppm): 2.40 (s, 3H, CH3), 4.78–5.25 (s, 2H, CH2),
6.21 (s, H, CH), 6.91–8.03 (12H, arom), 8.21 (s, H, CH), 11.98 (s, H, NH); 13C-NMR (ppm): 18.1, 65.2,
101.4, 111.3, 112.1, 113.4, 116.5, 118.4, 125.3, 126.1, 126.4, 133.6, 1370.5, 153.3, 154.5; MS m/z: 439.20
[M + H]+, (Mr = 438.82).
3.5. Determination of DPPH Scavenging Activity
DPPH scavenging activity for previously synthesized compounds [
(30–
36) was performed according to the procedure described in our previous work [4
]. For each sample,
antioxidant activity determination was performed in triplicate and expressed as % scavenging activity
(% DPPH).
3.6. QSAR Studies
3.6.1. Data Set
The dataset used for building QSAR models consists of 36 molecules whose antioxidant activities
were measured and described in the present study. Antioxidant activity, expressed as % DPPH), were
converted in the form of the logarithm (log % DPPH) and presented in Table 1 together with structures
of molecules (While transformation of the experimental data to both logit % DPPH and log %DPPH
afforded a normal distribution, the latter approach afforded a QSAR model, which appears to provide
a better relationship between the structures of the molecules and their activities).